In March 2025, the company announced new strategies for any direct-to-customer providing of its Wegovy weight loss drug. The company set up a completely new pharmacy, known as NovoCare, which would charge prospects $499 each month for entry to the drug, less than 50 % the price of the drug via other pharmaceutical distribution networks.[fifty three